Eurofins Bioanalytical Services expands technology footprint with the addition of Novocyte Quanteon™

Kristy Galkowski, Marketing Manager, Eurofins BioPharma Bioanalytical Services, US, KristenGalkowski@eurofins.com

Today’s leading scientists continuously seek new approaches to achieve a more holistic understanding of the cell and cellular mechanisms. These highly differentiated cellular workflows provide a deeper insight into live cell samples by providing both quantitative and phenotypic results, faster. The Quanteon is a 4 laser flow cytometer that can be configured with up to 25 independent photomultipliers for meeting the most demanding sample panels. The proprietary photomultiplier technology employed in the Quanteon provides superior sensitivity, stability, and a 7.2 log dynamic range. When developing large colour panels, the Quanteon saves hours of setup and analysis time. Superior fluidics provide steady and consistent sample delivery, with high reproducibility and absolute counts, without the use of expensive beads, which will save clients time and money.

Complementing its existing suite of Flow Cytometry platforms, this technology is highly advantageous for use in decision-making throughout the drug development life cycle, from early preclinical through to late phase clinical studies.

Eurofins commitment is to stay at the forefront of technology by offering the optimal choice in a fit-for-purpose approach. Its scientists now have the flexibility to choose from 25 fluorescent channels from a combination of four lasers (405, 488, 561, and 637nm) and superior sensitivity and resolutions to meet clients’ needs. Eurofins Bioanalytical Services custom designs biomarker solutions in a regulated or non-regulated environment based upon Context of Use to match clients’ drug development programmes.

With industry-leading biomarker solutions, complemented with traditional ligand-binding assays and study management services, clients can accelerate research outcomes with early proof-of-concept studies and throughout the development life cycle.

For more information, visit: www.eurofins.com/bioanalyticalservices